Libra Infusions Limited

LIBRAINFU

BD0471LBINF8

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 03:30:00 20/05/2024 am IST			5-day change	1st Jan Change
676.9 ^BDT	+0.67%		-4.62%	-26.48%

2023	Libra Infusions Limited Announces Cash Dividend for the Year Ended June 30, 2021	CI
2023	Libra Infusions Limited Announces Expansion of Large Brand New Dialysis Fluid Production Plant	CI

Libra Infusions Limited Announces Unaudited Financial Results for the First Quarter of 2019

November 28, 2018 at 03:33 pm IST

Libra Infusions Limited announced unaudited financial results for the first quarter of 2019. The company announced that the increase in EPS in the latest quarter in comparison to that of the previous quarter was due to increase in sales by 47.50% and decrease in cost compared to last quarter.

Latest news about Libra Infusions Limited

Libra Infusions Limited Announces Cash Dividend for the Year Ended June 30, 2021	12/11	CI
Libra Infusions Limited Announces Expansion of Large Brand New Dialysis Fluid Production Plant	07/11	CI
Libra Infusions Limited Recommends Cash Dividend	24/22/24	CI
Libra Infusions Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	03/19/03	CI
Libra Infusions Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2018	29/19/29	CI
Libra Infusions Limited Announces Unaudited Financial Results for the First Quarter of 2019	28/18/28	CI
Libra Infusions Limited Announces Financial Results for the Year Ended June 30, 2018	29/18/29	CI
Libra Infusions Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 2018	30/18/30	CI
Libra Infusions Limited Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2017	15/17/15	CI
Libra Infusions Limited Recommends Cash Dividend for the Year Ended on June 30, 2017	26/17/26	CI
Libra Infusions Limited Reports Earnings Results for the Year Ended on June 30, 2017	26/17/26	CI
Libra Infusions Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	27/17/27	CI
Libra Infusions Limited Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2016	05/17/05	CI
Libra Infusions Ltd. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2016	16/16/16	CI
Libra Infusions Ltd. Reports Earnings Results for the Year Ended June 30, 2016	30/16/30	CI

Chart Libra Infusions Limited

Duration

Period

More charts

Company Profile

Libra Infusions Ltd is a Bangladesh-based company engaged in manufacturing of Intravenous (I.V.) fluid. The Company's products include LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400 AND LIBRET. Its products are medical necessities used in medical situations involving diarrheal disease, surgical operation, loss of blood, weakness and hospitalization in general. LIBOTT is used for rehydration at the time of water deficit, general weakness and post-surgical intervention. LIBOTT-10 is used for the treatment of jaundice, general weakness, eclampsia and pre-eclampsia. LIBOTT-25 is used in the emergency treatment of severe hypoglycemia. LIBOTT-S is used for rehydration during general weakness, water deficiency along with sodium, diuresis, intoxication and post-surgical intervention. LIBOTT-S JR fulfills water deficit along with low deficiency of sodium chloride and supplies energy for growing children.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LIBRA INFUSIONS LIMITED	-26.48%	1.29Cr
ELI LILLY AND COMPANY	+34.35%	69TCr
NOVO NORDISK A/S	+29.39%	58TCr
JOHNSON & JOHNSON	-3.49%	37TCr
MERCK & CO., INC.	+20.15%	33TCr
ABBVIE INC.	+6.19%	29TCr
ASTRAZENECA PLC	+14.11%	24TCr
ROCHE HOLDING AG	-3.03%	21TCr
NOVARTIS AG	+10.02%	21TCr
AMGEN INC.	+9.21%	17TCr

Other Pharmaceuticals